REFER investigated the impact of the FreeStyle Libre system on A1c in type 2 diabetes (T2D) managed with basal-bolus insulin treatment.1 Real-world data were collected in 3 parallel, retrospective, non-interventional chart review studies of type 2 diabetes patients using the FreeStyle Libre system at diabetes centres in Austria, France and Germany. In these real-world settings, using the FreeStyle Libre system for 3–6 months significantly reduced A1c levels in people with T2D managed with basal-bolus insulin therapy.
Uw verzoek kon niet worden verwerkt.
The request can't be understood by the server due to malformed/invalid input.
Google ReCaptcha could not be verified. Please try again.
Internal server error. try again later.
STAY CONNECTED